Air ambulance get keys to new base near Southampton Airport
"We want to be there for you, wherever you live, on the worst day of your life and get to you as quickly as possible. And we're confident this new airbase will enable us to do that a lot better," Dr Hughes said. Once finished, the building will include facilities for an Airbus H135 helicopter, multiple emergency vehicles and a new aftercare support centre to help bereaved families. But Dr Hughes said the biggest difference would be reduced response times. He said more than 70% of callouts were currently south of Winchester, so the location of the new base would allow them to "reach the majority of people really, really quickly".
In April 2024 Julian Pearce suffered a cardiac arrest and his heart stopped beating for two minutes. Speaking at the transfer of keys at the new base, he said: "My life was saved... because somebody out there had actually made a donation to allow this [service] to function." The ambulance service said it was £2.4m away from its £3.6m target to transform the building so it was fit for purpose - with funding coming solely from public donations.
You can follow BBC Hampshire & Isle of Wight on Facebook, X (Twitter), or Instagram.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
16 minutes ago
- BBC News
The doctor fighting for women's health on Ukraine's front line
In a rural village close to the Ukrainian front line, a group of women queue quietly outside a purple and white ambulance, waiting to be seen by a doctor with his shaved head dyed the blue and yellow of the Ukrainian many of them, it's their first time seeing a doctor since the war began more than three years 2022, Dr Serhii Baksheiev, 53, has carried out more than 1,000 gynaecological examinations on women throughout front-line and occupied areas in his kitted out mobile clinic - named 'The Feminine Shuttle' and complete with a bright pink examination chair. "This is a humanitarian volunteering mission. It's for people who need help, in places where there are no doctors or hospitals, and it's absolutely free," he war with Russia has placed a huge strain on Ukraine's healthcare system, with more than 1,940 attacks on health facilities since the invasion, according to the World Health Organization (WHO) - making it the highest number in any humanitarian crisis to date - and with a significant increase in those attacks since December the war began, Dr Baksheiev, who is an obstetrician and gynaecologist, initially spent his days in a bunker in Kyiv helping to deliver babies as bombs fell above. The idea for an on-the-road clinic came to him, he says, after later medical volunteer missions to the front line revealed the lack of facilities because medical centres and hospitals had been completely destroyed."We went to Kharkiv and Chernihiv, which were very damaged, and the most difficult thing was not being able to provide gynaecological services because there were no tools and equipment, because everything was ruined," he Baksheiev and his team would have to use anything available as an examination table, including old sofas, meaning he would have to kneel on the floor to conduct walking around the electric vehicle, it's clear Dr Baksheiev is incredibly proud of its capabilities: it's been kitted out with everything he and his team could need in these remote areas, including an ultrasound machine and medical equipment to carry out minor surgeries. During a two-day mission the team can perform up to 80 colposcopies - where they examine the cervix and vulva for signs of cancerous or pre-cancerous work is crucial to the people living in these remote areas. His visits to small rural villages occupied by the Russians are often carried out in secret. He and his team slip in for a day or two to carry out their examinations and leave before they are provided by Ukraine's public health ministry and seen by the BBC show detection rates for ovarian and cervical cancers are down by 17% and 10% respectively since when doctors like Dr Baksheiev do get into those areas to perform examinations, they are finding a higher than average incidence of malignant tumours. On average, up to 4% of all women are diagnosed with malignant tumours after being examined, according to FRIDA Ukraine, the medical organisation Dr Baksheiev volunteers Ulana Supron was Ukraine's health minister from 2016 to 2019. She says there is a concern about the "ticking time bomb" of health outcomes as the war drags on."In the public health community, there definitely is a lot of worry about what's going to happen as the war continues," she says. "Not only in terms of physical health, but also mental health - because there is a constant stress, constant psychological trauma happening." Dr Supron says the government has managed to partially or fully rebuild as many as 964 medical facilities that were damaged by Russia. "They're working closely with the WHO and with other international organisations to try to come up with a plan on how we can rebuild the health system that was in place prior to Russia's invasion," she a cancer diagnosis himself in September 2024, Dr Baksheiev continues to volunteer and provide treatment to women across the country."Apart from the medical examination, you also hear them out because a lot of patients have stories about how the Russians attacked their villages," he says. "So we are not only doctors, we're the therapists for these patients."
The Independent
30 minutes ago
- The Independent
Persistent and widespread medicine shortages putting patients at risk
Patients are facing serious harm due to persistent and widespread medicine shortages, MPs and peers have warned in a new report. The All-Party Parliamentary Group (APPG) on pharmacy called for urgent action to prevent critical shortfalls from becoming the "new normal", highlighting the impact that shortages are having on patients with ADHD, menopause and diabetes. Steve Race, chairman of the APPG on pharmacy, said many MPs 'have received a growing volume of correspondence from constituents who are understandably anxious about the availability of their medicines'. 'Whether it is a parent unable to access antibiotics for a sick child, an elderly patient facing delays in obtaining life-sustaining medication, or a pharmacist overwhelmed by the need to source alternatives, the human impact is both visible and deeply troubling,' he wrote in the report. The report said that while medicine shortages are 'not a new phenomenon', they have 'become increasingly severe, persistent, and disruptive' in recent years – leading to consequences for patients, staff and the wider health service. 'Medicines shortages have moved from isolated incidents to a chronic structural challenge for both the NHS and pharmacy sector,' he said. 'As the government continues to recognise and invest in the expanded clinical role of community pharmacy, we must ensure the medicines supply chain underpinning that care is equally robust, resilient and patient-focused. 'Pharmacy is central to NHS recovery and transformation, but frontline teams cannot safely expand clinical services while daily supply disruptions continue to impact the health of patients.' The findings also highlight how shortages severely impact patients with conditions like ADHD, menopause and diabetes. More than nine in 10 pharmacists, GPs and prescribers told an APPG survey ADHD medicines had been affected by shortages. Around three-quarters (76 per cent) said HRT and diabetes drugs had been affected, while 44 per cent said antibiotics. One patient with ADHD told the inquiry they had been self-medicating with cannabis due to an ongoing shortage of methylphenidate. The report said: 'These shortages are having a significant impact on patients' ability to access treatments and in some cases are having serious impact on patients' health and well-being.' Mr Race added: 'Medicines security must be treated as a core component of NHS planning, alongside funding, workforce and digital infrastructure. 'Failure to act risks further undermining patient care and destabilising a community pharmacy sector that millions depend upon.' The APPG has laid out a number of recommendations, which include a number of measures to better support patients. People impacted by shortages, particularly those with chronic conditions, struggle to find information on out-of-stock drugs, leading to 'frustration, dangerous delays in care, and unnecessary anxiety and harm', it said. It also welcomed work being carried out by the Department of Health and Social Care to potentially change pharmacist prescribing protocols to allow pharmacists to make dose and formulation changes during shortages. Elsewhere, the inquiry found more than eight in 10 pharmacists face daily shortages, with many spending hours every day finding alternative treatment and communicating with distressed patients. One told the APPG they are 'constantly firefighting'. Reacting to the report, Henry Gregg, chief executive of the National Pharmacy Association (NPA), said: 'Pharmacy teams are under enormous pressure but are forced to spend hours hunting down stock for distressed and frustrated patients. 'It is particularly frustrating for pharmacists to be unable to meet a clear need when they have a perfectly safe and effective solution in their pharmacy already. 'MPs are right that it is madness to send someone back to their GP to get a prescription changed, and it risks a patient either delaying taking vital medication or forgoing it altogether, which poses a clear risk to patient safety. 'As the APPG says, the Government must allow pharmacists – who are highly trained health care practitioners – to use their professional judgment to supply an appropriate alternative medication when the prescribed version is unavailable.' A Department of Health and Social Care spokesperson said: 'This government inherited ongoing global supply problems, but we have robust measures in place to mitigate disruption for patients. 'We are working to build the resilience of medicine supply chains and prevent future disruption as we get the NHS back on its feet. 'We have recently agreed an extra £617 million of funding over two years with Community Pharmacy England to support the sector and provide patients with more services closer to home as part of our 10 Year Health Plan.'
The Independent
30 minutes ago
- The Independent
Mother of two becomes the first UK patient to receive ‘groundbreaking' new diabetes drug
A mother of two has become the first adult in the UK to try a 'groundbreaking' drug which can delay the need for insulin in diabetes patients. Hannah Robinson, a 36-year-old dentist, is being treated with teplizumab at Royal Devon University Healthcare NHS Foundation Trust after discovering during pregnancy she was in the early stages of developing type 1 diabetes. A handful of people are also being given the medicine on a case-by-case basis while it is reviewed for wider use on the NHS. With type 1 diabetes, the immune system attacks insulin -producing cells in the pancreas, meaning blood sugar levels are no longer regulated by the body and people with the condition, therefore, need daily insulin. If blood sugar is too high or too low, it can cause serious health problems and even death. Teplizumab, which is already approved in the US, trains the immune system to stop attacking pancreatic cells, delaying the need for insulin by an average three years. Ms Robinson said: 'For me, this new drug offers more freedom and the chance to focus on my health before I have to start thinking differently and managing life as somebody needing daily insulin. This isn't just about what I eat or monitoring my glucose, it is also about having more control and not feeling defined by my condition. This treatment could potentially pave the way for a future cure for type 1 diabetes, which is incredible. I feel very lucky to be part of this.' Teplizumab must be given at the earliest stage of the disease to be effective. Dr Nick Thomas, diabetes consultant and academic clinical lecturer at the University of Exeter, said: 'This new treatment represents a really exciting shift in how we manage type 1 diabetes. For the first time ever, we will be able to provide targeted treatment early enough in the process to alter the underlying immune process, aiming to slow down how quickly people need insulin. Approximately half of all type 1 diabetes cases develop in adulthood, and Hannah will be the first adult in the UK to receive this treatment. My hope is that in the future, we may be able to stop people with early type 1 diabetes from needing insulin at all.' Experts at the Royal Devon and the University of Exeter are using genetics and other testing to spot people at high risk of developing type 1 diabetes. The hope is that more people could be offered the drug to delay type 1. Dr Lucy Chambers, head of research impact and communications at Diabetes UK, said: 'For people in the early stages of type 1 diabetes, teplizumab offers a groundbreaking opportunity to buy them precious extra years insulin-free. 'Right now, it's only available in research settings – and while the excitement is real, urgent work is still needed to ensure it reaches everyone who could benefit. That means securing a UK licence for teplizumab, establishing national screening programmes to identify people with early-stage type 1 diabetes before symptoms appear, and preparing the NHS to deliver this treatment at scale. 'Diabetes UK is proud to be at the forefront of these efforts – funding pioneering research and working closely with the NHS towards a future where immunotherapies become the first-line treatment for tackling the autoimmune attack at the root of type 1 diabetes.'
